Ring Christine sold NRIX

November 24, 2025 · Form 4 insider transaction

Ring Christine sold 37,600 shares of Nurix Therapeutics, Inc. at $17.07 per share, a transaction worth $641.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
37,600
Price
$17.07
Total value
$641.7K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 24, 2025
Filing dateNovember 24, 2025
Shares owned after50,897
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.; Represents the weighted average sale price. The lowest price at which shares were sold was $17.00 and the highest price at which shares were sold was $17.26. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

View the original Form 4 on SEC EDGAR